Syntekabio Inc. Employee Directory
Biotechnology ResearchNew York, United States11-50 Employees
Syntekabio Inc. is a biotechnology research company that uses artificial intelligence to guide drug discovery and development. It combines AI insights with Next Generation Sequencing data and a robust genomic database, supported by its proprietary computing infrastructure, to forecast and identify promising molecular entities for therapeutic work. Headquartered in South Korea with a New York City hub serving its United States presence, the firm operates as a relatively small to mid-sized organization focused on AI-driven biotechnology research. It seeks collaborations with academic institutions, industrial partners, and government research labs to advance medical science on a global scale. A notable 2025 development was the launch of AI-driven Asset Programs designed to identify antibody and small-molecule drug candidates using its AI supercomputing platform.